Summary
The proliferation of the human promonocytic leukemia cell line U937 is inhibited by several ether lipids, ether lipid analogues and by phorbol esters. An early effect of this retardation of cell growth is the induction of a basic chromosomal protein, histone H10. Northern blot analysis of H10 mRNA levels reveals an increase of the mRNA concentration within a few hours after addition of hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. This early effect on the synthesis of a subtype of H1 proteins precedes the expression of several parameters of the monocytic differentiation of U937 cells.
Similar content being viewed by others
Abbreviations
- ES-16-OH:
-
1-O-palmitoyl-sn-glycero-3-phosphocholine
- ET-18-OCH3 :
-
1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
- He-PC:
-
hexadecylphosphocholine
- TPA:
-
12-O-tetraclecanoylphorbol 13-acetate
- He-PC6 :
-
hexadecylphospho(N,N,N-trimethylamino)-hexanol
References
Alonso A, Breuer B, Bouterfa H, Doenecke D (1988) Early increase in histone H10 mRNA during differentiation of F9 cells to parietal endoderm. EMBO J 7:3003–3008
Andreesen R, Giese V (1987) Differential effects of ether lipids on the activity and secretion of interleukin-1 and interleukin 2. Lipids 22:836–841
Aranzana-Seisdedos F, Mogensen SC, Vuillier F, Fiers W, Virelizer JL (1988) Autocrine secretion of tumor necrosis factor under the influence of interferon-gamma amplifies HLA-DR gene induction in human monocytes. Proc Natl Acad Sci USA 85:6087–6091
Babior B (1978) Oxygen-dependent microbial killing by phagocytes. N Engl J Med 12:659–666
Banchev R, Srebreva L, Zlatanova J, Tsanev R (1988) Immunofluorescent localization of histone H10 in the nuclei of proliferating and differentiating Friend cells. Exp Cell Res 177:1–8
Berdel WE, Bausert WRE, Fink U, Rastetter J, Munder PG (1981) Anti-tumor action of alkyl-lysophospholipids. Anticancer Res 1:345–352
Bouterfa H, Doenecke D, Löffler M (1990) Increased level of histone H10 mRNA in hypoxic Ehrlich ascites tumor cells. Exp Cell Res 188:160–163
Cabanas S, Sanchez-Madrid F, Acevedo A, Bellon T, Fernandez JM, Larraga V, Bernabev C (1988) Characterization of a SD11-reactive monoclonal antibody (HC1/1) obtained by immunizing with phorbol ester differentiated U937 cells. Hybridoma 7:167–176
Chabanas A, Khoury E, Goeltz P, Froussard P, Gjerset R, Dod B, Eisen H, Lawrence JJ (1985) Effects of butyric acid on cell cycle regulation and induction of histone H10 in mouse cells and tissue culture. J Mol Biol 183:141–151
Cheng G, Skoultchy AI (1989) Rapid induction of polyadenylated H1 histone mRNAs in mouse erythroleukemia cells is regulated by c-myc. Mol Cell Biol 9:2332–2340
Chirgwin J, Przybyla A, MacDonald R, Rutter W (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
D'Anna JA, Gurley LR, Tobey RA (1982) Synthesis and modulations in the chromatin contents of histones H10 and H1 during G1 and S phases in chinese hamster cells. Biochemistry 21:3991–4001
D'Incalci M, Allavena P, Wu RS, Bonner WM (1986) H1 variant synthesis in proliferating and quiescent human cells. Eur J Biochem 154:273–279
Doenecke D, Tönjes R (1986) Differential distribution of lysine and arginine residues in the closely related histones H10 and H5. J Mol Biol 187:461–464
Eibl H (1981) Synthesis of phospholipids. In: Knight CG (ed) Liposomes, from physical structure to therapeutic application. Elsevier, Amsterdam, pp 19–50
Eick S, Nicolai M, Mumberg D, Doenecke D (1989) Human H1 histones: conserved and varied sequence elements in two H1 subtype genes. Eur J Cell Biol 49:110–115
Faltynek CR, Finch LR, Miller P, Overton WR (1989) Treatment with recombinant IFN-gamma decreases cell surface CD4 levels on peripheral blood monocytes and on myelomonocyte cell lines. J Immunol 142:500–508
Gabrielli F, Aden D, Carrel SC, von Bahr C, Rane A, Angeletti CA, Hancock R (1985) Histone complements of human tissues, carcinomas and carcinoma derived cell lines. Mol Cell Biochem 65:57–66
Gavison R, Matzner Y, Fibach E (1988) Differential induction of monocytic functions by dibutyryl cyclic AMP and retinoic acid in a human monoblast cell line U937. Isr J Med Sci 24:697–701
Geissler K, Harrington M, Srivastava C, Leemhuis T, Tricot G, Broxmeyer HE (1989) Effects of recombinant human colony stimulating factor (CSF) (granulocyte-macrophage CSF, granulocyte CSF and CSF-a) on human monocyte/macrophage differentiation. J Immunol 143:140–146
Gidlund M, Orn A, Pattengale PK, Jansson M, Wigzell H, Nilsson K (1981) Natural killer cells kill tumor cells at a given stage of differentiation. Nature 292:848–850
Gjerset R, Gorka C, Hasthorpe S, Lawrence JJ, Eisen H (1982) Developmental and hormonal regulation of protein H10 in rodents. Proc Natl Acad Sci USA 79:2333–2337
Hall JM, Davis C, Cole RD (1985) Induction of H10 differs with different treatments among different cell lines. FEBS Lett 189:92–96
Hass R, Bartels H, Topley N, Hadam M, Köhler L, Goppelt-Strube M, Resch K (1989) TPA induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. Eur J Cell Biol 48:282–293
Hilgard P, Stekar J, Vögeli H, Engel J, Schumacher W, Eibl H, Unger C, Berger MR (1988) Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). Eur J Cancer Res Clin Oncol 24:1457–1461
Hilgard P, Harlemann JH, Voegeli R, Maurer HR, Echarti C, Unger C (1989) The antineoplastic activity of hexadecylphosphocholine (HPC) is associated with tumor cell differentiation. Proc Am Assoc Cancer Res 30:2310
Hochhuth C, Doenecke D (1990) The expression of the histone H10 gene in the human hepatoma cell line HepG20 is independent from the state of cell proliferation. Differentiation 43:212–219
Honma Y, Kasukabe T, Okabe-Kado J, Hozumi M, Tusushima S, Nomura H (1981) Induction of differentiation of cultured human and mouse myeloid cells by alkyllysophospholipids. Cancer Res 41:3211–3216
Honma Y, Kasukabe T, Okabe-Kado J, Hozumi M, Tusushima S, Nomura H (1983) Antileukemic effect of alkylphospholipids. I. Inhibition of proliferation and induction of differentiation of cultured myeloid leukemia cells by alkylethyleneglycophospholipids. Cancer Chemother Pharmacol 11:73
Keppel F, Allet B, Eisen H (1977) Appearance of a chromatin protein during the erythroid differentiation of Friend virus transformed cells. Proc Natl Acad Sci USA 74:653–656
Koeffler PH (1983) Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 62:709–721
Koeffler HP, Bar-Eli M, Territo M (1980) Phorbol diester induced macrophage differentiation of leukemic blasts from patients with myelogenous leukemia. J Clin Invest 66:1101–1104
Kress H, Tönjes R, Doenecke D (1986) Butyrate induced accumulation of a 2.3 kb polyadenylated H10 histone mRNA in HeLa cells. Nucleic Acids Res 14:7189–7197
Larsson LG, Ivhed I, Gidlund M, Pettersson R, Vennström B, Nilsson K (1988) Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene. Proc Natl Acad Sci USA 85:2638–2642
Lord KA, Hoffmann-Liebermann B, Liebermann DA (1990) Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants. Oncogene 5:387–396
McMaster GH, Carmichael GG (1977) Analysis of single and double stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci USA 74:4835–4838
Munder PG, Weltzien HU, Modolell M (1976) Immunopathology. In: Miescher PA (ed) VIIth International Symposium on Immunopathology. Schwabe, Basel, pp 411–424
Munder PG, Modolell M, Bausert W, Oettgen HF, Westphal O (1981) Alkyl-lysophospholipids in cancer therapy. In: Hersh EM, Chirigos MA, Mastrangelo MJ (eds) Augmenting agents in cancer therapy. Raven, New York, pp 441–458
Muschiol C, Berger MR, Schuler B, Scherf HE, Garzon FT, Zeller WJ, Unger C, Eibl H, Schmähl D (1987) Alkylphosphocholines: toxicity and anticancer properties. Lipids 22:930–934
Noma T, Nakakubo H, Hama K, Honjo T (1989) Multiple effects of human recombinant interleukin 4 on human myeloid monocyte cell lines. Immunol Lett 21:323–328
Osborne HB, Chabanas A (1984) Kinetics of histone H10 accumulation and commitment to differentiation in murine erythroleukemia cells. Exp Cell Res 152:449–458
Panyim S, Chalkley RG (1969) A new histone found only in mammalian tissue with little cell division. Biochem Biophys Res Commun 37:1042–1049
Pehrson J, Cole RD (1980) Histone H10 accumulates in growth inhibited cultured cells. Nature 285:43–45
Pieler C, Adolf GR, Swetly P (1981) Accumulation of histone H10 during chemically induced differentiation of murine neuroblastoma cells. Eur J Biochem 115:329–333
Pina B, Suau P (1987) Changes in the proportions of histone H10 subtypes in brain cortical neurons. FEBS Lett 210:161–164
Pina B, Martinez P, Simon L, Suau P (1984) Differential kinetics of histone H10 accumulation in neuronal and glial cells from rat cerebral cortex during postnatal development. Biochem Biophys Res Commun 123:697–702
Ralph P, Harris PE, Punjabi CJ, Welte K, Litcofsky PB, Ho MK, Rubin BY, Moore MAS, Springer TA (1983) Lymphokine inducing “terminal differentiation” of the human monoblast leukemia line U937. A role for interferon-gamma. Blood 62:1169
Rigby P, Dieckmann M, Rhodes C, Berg P (1977) Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol 113:237–251
Sheta B, Dransfield I, Partridge LF, Barker MD, Burton DR (1988) Dibutyryl cyclic AMP stimulation of a monocyte-like cell line, U937: a model for monocyte chemotaxis and Fc-receptor-related functions. Immunology 63:483–490
Smith BJ, Harris MR, Sigournay CM, Mayes ELV, Bustin M (1984) A survey of H10 and H5-like protein structures and distribution in higher and lower eukaryotes. Eur J Biochem 138:309–317
Sundström C, Nilsson K (1976) Establishment and characterization of a human histiocyte lymphoma cell line (U937). Int J Cancer 17:565–577
Testa U, Ferbus D, Gabbianelli M, Boccoli G, Louache F, Thang MN (1988) Effect of endogenous and exogenous interferons on the differentiation of human monocyte cell line U937. Cancer Res 48:82–88
Trinchieri G, Kobayashi M, Rosen M, Loudon R, Murphy M, Perussia B (1986) Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med 164:1206–1225
Unger C (1989) Alkylphosphocholine und Analoga. Entwicklung einer neuen Substanzgruppe mit antineoplastischer Wirkung. Thieme, Stuttgart, S 1–106
Unger C, Eibl H (1990) Hexadecylphosphocholine: preclinical and first clinical results of a new antitumor drug. Lipids (in press)
van Helden PD (1985) Histone H10: a maintainer of the differentiated cell state? Int J Biochem 17:381–385
Vehmeyer K, Kim DJ, Nagel GA, Eibl H, Unger C (1989) Effect of ether lipids on mouse granulocyte-macrophage progenitor cells. Cancer Chemother Pharmacol 24:58–60
Ways DK, Dodd RC, Bennett TE, Hooker JL, Earp HS (1988) Effect of retinoic acid on phorbol ester-stimulated differentiation and protein kinase c-dependent phosphorylation in the U937 human monoblastoid cell. Cancer Res 48:5779–5787
Yunis J, Band H, Bonneville F, Yunis EJ (1989) Differential expression of MHC class II antigens in myelomonocytic leukemia cell lines. Blood 73:931–937
Zlatanova JS (1980) Synthesis of histone H10 is not inhibited in hydroxyurea treated Friend cells. FEBS Lett 112:199–202
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. D. Schmähl on the occasion of his 65th birthday
Supported by the Deutsche Forschungsgemeinschaft (D.D.) and the Ministry for Research and Technology (C.U.)
Rights and permissions
About this article
Cite this article
Hochhuth, C., Berkovic, D., Eibl, H. et al. Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells. J Cancer Res Clin Oncol 116, 459–466 (1990). https://doi.org/10.1007/BF01612994
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01612994